Pembrolizumab for Microsatellite-Instability–High Advanced Colorectal Cancer
David H. Ilson
Abstract
Single-agent therapy and combination immune checkpoint inhibitor therapy are now approved for microsatellite-instability (MSI)–high colorectal cancer
Topics & Concepts
Microsatellite instabilityPembrolizumabMedicineColorectal cancerCancerOncologyInternal medicineMicrosatelliteGeneticsBiologyImmunotherapyGeneAlleleGenetic factors in colorectal cancerColorectal Cancer Treatments and StudiesCancer Immunotherapy and Biomarkers